Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma

  • David T. Teachey
  • , Meenakshi Devidas
  • , Brent L. Wood
  • , Zhiguo Chen
  • , Robert J. Hayashi
  • , Michelle L. Hermiston
  • , Robert D. Annett
  • , J. Hunter Archer
  • , Barbara L. Asselin
  • , Keith J. August
  • , Steve Y. Cho
  • , Kimberly P. Dunsmore
  • , Brian T. Fisher
  • , Jason L. Freedman
  • , Paul J. Galardy
  • , Paul Harker-Murray
  • , Terzah M. Horton
  • , Alok I. Jaju
  • , Allison Lam
  • , Yoav H. Messinger
    • Rodney R. Miles, Maki Okada, Samir I. Patel, Eric S. Schafer, Tal Schechter, Neelam Singh, Amii C. Steele, Maria Luisa Sulis, Sarah L. Vargas, Stuart S. Winter, Charlotte Wood, Patrick Zweidler-Mckay, Catherine M. Bollard, Mignon L. Loh, Stephen P. Hunger, Elizabeth A. Raetz

Research output: Contribution to journal › Article › peer-review

125   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology